NASDAQ:TDAC
Translational Development Acquisition Corp.
Translational Development Acquisition Corp. reported net income of $6.4M in fiscal 2025.Summary generated from Translational Development Acquisition Corp.'s SEC filings. Latest annual report filed Mar 30, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | n/a | n/a | n/a |
| Operating income | −0 | −0 | −1 |
| Net income | −0 | −0 | 6 |
| Free cash flow | n/a | n/a | n/a |
Recent filings
- 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KEntry into a material agreement
Jul 27, 2026 - 8-KOther events
Jul 8, 2026 - 8-KOther events
Jun 23, 2026 - 8-KEntry into a material agreement
Jun 18, 2026 - 8-KCurrent report
Jun 12, 2026 - 4Insider transaction report
May 29, 2026 - DEF 14AProxy statement
May 27, 2026